Methotrexate
About
Therapy type: Chemotherapy
Therapy strategy: Antifolate
Mappings
NCI Thesaurus: Methotrexate (ncit:C642)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.| Type | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| Sensitivity (+) | BCR::ABL1 | Acute Lymphoid Leukemia | Cytarabine, Methotrexate, Ponatinib, Prednisone, Vincristine | |
| Sensitivity (+) | CD20 + | Diffuse Large B-Cell Lymphoma | Corticosteroid, Cyclophosphamide, Cytarabine, Doxorubicin, Etoposide, Methotrexate, Rituximab, Vincristine | |
| Sensitivity (+) | CD20 + | Non-Hodgkin Lymphoma | Corticosteroid, Cyclophosphamide, Cytarabine, Doxorubicin, Etoposide, Methotrexate, Rituximab, Vincristine | |
| Sensitivity (+) | CD20 + | Burkitt Lymphoma | Corticosteroid, Cyclophosphamide, Cytarabine, Doxorubicin, Etoposide, Methotrexate, Rituximab, Vincristine |